A retrospective study of clinical use of recombinant human erythropoietin for treatment in anemic dogs with canine monocytic ehrlichiosis from an animal hospital in Bangkok, Thailand

被引:3
作者
Assarasakorn S. [1 ]
Kaewthamasorn M. [2 ]
Manachai N. [3 ]
机构
[1] Academic Affairs, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Henri-Dunant Rd.
[2] Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Henri-Dunant Rd.
[3] Small Animal Teaching Hospital, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Henri-Dunant Rd.
关键词
Anemia; Ehrlichiosis; Erythropoietin; Hematology; Retrospective study; Serum biochemistry;
D O I
10.1007/s00580-008-0748-9
中图分类号
学科分类号
摘要
Canine monocytic ehrlichiosis (CME) is an important tick-borne transmitted disease in tropical and subtropical areas worldwide. Its major laboratory findings include thrombocytopenia, leukopenia, and anemia. Recombinant human erythropoietin (r-HuEPO), a glycoprotein hormone that stimulates the proliferation, maturation, and differentiation of erythrocytes, has been generally used for treatment of anemia in dogs with CME-induced severe anemia. Evaluation of treatment with r-HuEPO in dogs with CME with or without concurrent renal insufficiency has never been addressed. The objective of the present study was to evaluate the clinical use of r-HuEPO in CME-induced anemic dogs. A retrospective study was performed for the period from January 2006 to November 2006 in dogs admitted to Chulalongkorn Small Animal Teaching Hospital, Bangkok, Thailand. Dogs were divided into two groups based on clinical signs of normal and abnormal kidney function, respectively. The laboratory based parameters of hematology and serum biochemistry profiles of CME-induced anemic dogs before and during r-HuEPO treatment were measured weekly. The results revealed that all the dogs in both groups had an erythroid response to r-HuEPO treatment. Exogenous administration of r-HuEPO had no effect on leukocyte and platelet counts as well as serum biochemistry in these dogs. It is likely that the clinical use of r-HuEPO is a very important approach to be considered in the management of severe anemia in dogs with ehrlichiosis. © Springer-Verlag London Limited 2008.
引用
收藏
页码:237 / 243
页数:6
相关论文
共 26 条
[1]  
Assarasakorn S., Niwetpathomwat A., A retrospective study of blood transfusion in dogs from a veterinary hospital in Bangkok, Thailand, Comp Clin Pathol, 15, pp. 191-194, (2006)
[2]  
Bonfanti U., Zini E., Minetti E., Zatelli A., Free light-chain proteinuria and normal renal histopathology and function in 11 dogs exposed to Leishmania infantum, Ehrlichia canis, and Babesia canis, J Vet Intern Med, 18, pp. 618-624, (2004)
[3]  
Brazzell J.L., Weiss D.J., A retrospective study of aplastic pancytopenia in the dog: 9 cases (1996-2003), Vet Clin Pathol, 35, pp. 413-417, (2006)
[4]  
Breitschwerdt E.B., Hegarty B.C., Hancock S.I., Doxycycline hyclate treatment of experimental canine ehrlichiosis followed by challenge inoculation with two Ehrlichia canis strains, Antimicrob Agents Chemother, 42, pp. 362-368, (1998)
[5]  
Cases A., Escolar G., Reverter J.C., Ordinas A., Lopez-Pedret J., Revert L., Castillo R., Recombinant human erythropoietin treatment improves platelet function in uremic patients, Kidney Int, 42, pp. 668-672, (1992)
[6]  
Codner E.C., Caceci T., Saunders G.K., Smith C.A., Robertson J.L., Martin R.A., Troy G.C., Investigation of glomerular lesions in dogs with acute experimentally induced Ehrlichia canis infection, Am J Vet Res, 153, pp. 2286-2291, (1992)
[7]  
Cowgill L.D., Medical management of the anemia of chronic renal failure, Canine and Feline Nephrology and Urology, pp. 539-554, (1995)
[8]  
de Castro M.B., Machado R.Z., de Aquino L.P., Alessi A.C., Costa M.T., Experimental acute canine monocytic ehrlichiosis: Clinicopathological and immunopathological findings, Vet Parasitol, 119, pp. 73-86, (2004)
[9]  
Frank J.R., Breitschwerdt E.B., A retrospective study of ehrlichiosis in 62 dogs from North Carolina and Virginia, J Vet Intern Med, 13, pp. 194-201, (1999)
[10]  
Harrus S., Waner T., Weiss D.J., Keysary A., Bark H., Kinetics of serum antiplatelet antibodies in experimental acute canine ehrlichiosis, Vet Immunol Immunopathol, 51, pp. 13-20, (1996)